CVS compared with GILD: revenue, margins and what each company keeps, and the suppliers and customers both name

CVSCVS Health Corp

Mkt capRevenueRevenue

GILDGilead Sciences, Inc.

Mkt capRevenueRevenue

Compare

CVSCVS Health Corp

GILDGilead Sciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CVS

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.9%▼−12.53%×2.12

Q2 FY26±4.9%▼−5.08%×1.04

Q1 FY26±5.7%▲+7.65%×1.35

Feb 10 '26±5.3%▼−0.09%×0.02

GILD

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.4%▲+3.06%×0.91

Q2 FY26±4.6%▼−2.58%×0.57

= impliedCVS realized, solidGILD realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Q1 FY26

±4.0%

▼−2.04%

×0.50

Feb 11 '26±4.6%▲+5.82%×1.26

CVSCVS Health Corp

83.86▲+3.11%· post 84.24

Mkt cap$107.3BRevenue$108BQ3 FY26Revenue$402BFY25

GILDGilead Sciences, Inc.

166.97▼−0.36%· post 167.32

ClosedNov 6 '26

Mkt cap$207.0BRevenue$8.3BQ3 FY26Revenue$29.4BFY25

Compare

ClosedNov 6 '26

CVSCVS Health Corp

GILDGilead Sciences, Inc.

83.86▲+3.11%post 84.24

Price

166.97▼−0.36%post 167.32

$107.3B

Mkt cap

$207.0B

Q3 FY26$108B

Revenue

$8.3BQ3 FY26

FY25$402B

Revenue

$29.4BFY25

CVS83.86▲+3.11%vsGILD166.97▼−0.36%ClosedNov 6 '26